AC Immune SA annual ebitda
2015
2016
2017
2022
2023
2024
2025
AC Immune SA EBITDA Growth & History (ACIU)
AC Immune SA's calculated EBITDA was −CHF67.8M for fiscal 2025.
View full AC Immune SA company overviewAC Immune SA annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −CHF67.8M | −CHF19.1M | — |
| 2024 | 2024-12-31 | −CHF48.6M | CHF3.2M | — |
| 2023 | 2023-12-31 | −CHF51.8M | CHF16.2M | — |
| 2022 | 2022-12-31 | −CHF68.0M | — | — |
| 2017 | 2017-12-31 | −CHF22.0M | −CHF11.8M | — |
| 2016 | 2016-12-31 | −CHF10.2M | −CHF29.1M | — |
| 2015 | 2015-12-31 | CHF18.9M | — | — |
AC Immune SA quarterly ebitda
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | CHF1.9M | CHF22.5M | — |
| Q1 2026 | 2026-03-31 | −CHF14.7M | — | — |
| Q4 2025 | 2025-12-31 | −CHF13.7M | — | — |
| Q3 2025 | 2025-09-30 | −CHF15.2M | — | — |
| Q2 2025 | 2025-06-30 | −CHF20.5M | — | — |
AC Immune SA ebitda trends
Between the periods ended 2015-12-31 and 2025-12-31, AC Immune SA's ebitda decreased from CHF18.9M to −CHF67.8M, a change of −CHF86.7M. The latest reported quarter, Q2 2026, shows CHF1.9M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AC Immune SA source filings ↗